Global Non-Small Cell Lung Cancer Industry is expected to reach US$ 20 Billion by 2033, Says Recent Study FMI

A recently published study by Future Market Insights sheds light on the anticipated growth of the global non-small cell lung cancer industry. The study projects a Compound Annual Growth Rate (CAGR) of 7.2% from 2023 to 2033, culminating in a market valuation of US$ 20 Billion by the end of the assessment period. The non-small …

Global Non-Small Cell Lung Cancer Industry is anticipated to surge to US$ 20 Billion by 2033 with a stable 7.2% CAGR | FMI

A recently published study by FMI expects the global non-small cell lung cancer industry to augment at a 7.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 20 Billion is expected for the market. The industry experienced noteworthy growth, registering a value CAGR of 6.7% and closing at …